China Health EV / EBITDA
Cos'è EV / EBITDA di China Health?
EV / EBITDA di China Health Group Inc. è 7.21
Qual è la definizione di EV / EBITDA?
EV / EBITDA è il valore aziendale diviso per guadagni prima di interessi, tasse, deprezzamento e ammortamento. È una misura di quanto sia costosa una azione ed è più frequentemente valida per i confronti tra le aziende rispetto al rapporto prezzo / guadagno. Misura il prezzo (sotto forma di valore d'impresa) che un investitore paga a vantaggio del flusso di cassa della società (sotto forma di EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA di aziende nel Health Care settore su HKSE rispetto a China Health
Cosa fa China Health?
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Aziende con ev / ebitda simili a China Health
- Bowl America ha EV / EBITDA di 7.20
- Zhejiang Chang'an Renheng Technology Co ha EV / EBITDA di 7.20
- Intense Technologies ha EV / EBITDA di 7.20
- Zenitel NV ha EV / EBITDA di 7.20
- Next Solar Fund ha EV / EBITDA di 7.20
- DS Smith Plc ha EV / EBITDA di 7.21
- China Health ha EV / EBITDA di 7.21
- Bodal Chemicals ha EV / EBITDA di 7.21
- V2X Inc ha EV / EBITDA di 7.21
- Hertz Global ha EV / EBITDA di 7.21
- Information Services ha EV / EBITDA di 7.21
- Pathward Inc ha EV / EBITDA di 7.21
- Impellam PLC ha EV / EBITDA di 7.22